Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SNOFF 3 now
next one around 3.50 ?
Yep - not bad!
up 34% now 2.63 2.64... SNOFF looking good into last half hour of trading
SHZ now up 38% 3.40 x 3.42
MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
MARIETTA, Ga., June 22, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials including bioimplants processed from human amniotic membrane, announced today that the Company's proprietary device, HydroFix™ Ortho Shield™, has received 510(k) clearance. The Company also announced its receipt of two additional 510(k) clearances related to its HydroFix™ technology platform.
HydroFix™ Ortho Shield™ is indicated for the management and protection of tendon injuries in which there has been no substantial loss of tendon tissue. The patented HydroFix™ Ortho Shield™ is a biocompatible polyvinyl alcohol polymer (PVA) membrane that is indicated to minimize tissue attachment to the device in case of direct contact with the tissues. HydroFix™ Ortho Shield™ is a permanent protective sheet that minimizes soft tissue attachments to the device providing a protective environment for the repaired tendon to heal. The device is conformable, suturable, and biocompatible, providing surgeons with an easy to use option for tendon protection. The device also provides a smooth inner gliding surface for the tendon to move as part of normal motion.
Parker H. "Pete" Petit, Chairman and CEO, said, "We are pleased to receive these FDA clearances. Soft tissue attachments to repaired tendons can reduce the effectiveness of the repair and result in a reduced range of motion post surgery, so the HydroFix™ Ortho Shield™ meets an important clinical need. We are continuing to develop additional indications for this biomaterial in response to surgeon demand for a wide range of applications."
The two additional 510(K) clearances recently received from the FDA were for the Company's HydroFix™ Vaso Shield device. HydroFix™ Vaso Shield, indicated for use as a cover for vessels during anterior vertebral surgery, has now received clearance for an expanded range of sizes and for a higher temperature exposure limit. Additionally, a large animal implantation study has demonstrated the ability of the device to minimize soft tissue attachments between the device and the surrounding soft tissue.
Bill Taylor, President and COO, stated, "Receiving these additional FDA clearances for our HydroFix™ technology is an important step in serving the needs and preferences of physicians that are utilizing our device in their surgical procedures. Surgeon feedback has included requests for new indications for use and new sizes for existing indications, and these new 510(k) clearances are a direct result of a portion of that surgeon feedback. These FDA clearances are an integral part of our strategy of providing biomaterial solutions to unmet or underserved physician needs."
Oops sorry, I forgot it is OTC
MDXG FDA clearance
MDXG FDA clearance, moving
Excellent!
Looks like we will hold 2.30 today imo
Good point.
hopefully bottom fisher institutions will start showing up with Form 4's
Moving again here 2.50+
TLB consolidating imo
AMHD pretty thin
AMHD news and uptick, worth a look
Nice news for AMHD
Agreed. High volatility but lots of trading opps
SNOFF 2.48... coming back
Current video discussions on Sino Forest SNOFF/TRE
http://www.cbc.ca/news/business/story/2011/06/17/sino-forest-panel.html :
Money manager John Goldsmith and investment advisor Susan Mallin were asked recently for their views on the stock.
CEO video posted on http://www.sinoforest.com/
http://cache.cantos.com/download/bruns-a113/bruns-a113-2_wbb.wmv
Paulson, THE largest institutional shareholder is already out.
Other institutions have sold already, thus the massive drop we have already seen. So, the likelihood of more "massive" institutional dumpage on a large scale is nil.
IMHO
SNOFF / TRE
SNOFF 2.00
It's doing very well today after the huge run yesterday. TLB is on its way to 4,...whether it breaks 3.75 today or not, I don't know.
With Paulson gone, are all the big institutional sellers out now?
SNOFF / TRE
nice bounce so far on SNOFF
Seems like it would be double that amount...
SNOFF won't see a halt, even if TRE does
Even Muddy Waters said 1 dollar price target SNOFF
watch for bounce 1.38 SNOFF
UPDATE: Sino-Forest Down 20%, Dips Below $2 as Largest Shareholder Exits, Gets Cut to Junk Status, RBC Suspends Coverage
Read more: http://community.nasdaq.com/News/2011-06/update-sinoforest-down-20-dips-below-2-as-largest-shareholder-exits-gets-cut-to-junk-status-rbc-suspends-coverage.aspx?storyid=81742#ixzz1Pv86DAgR
Retailer Talbots ended the session up 21% to $3.73 after a runup that started around 2:30 pm ET during the trading day. (Shares are falling about 3.5% in after-hours trading.)
Talbots said no one was available to comment, but analysts note that the company’s management was on the road last week meeting with institutional investors.
“Someone may have become intrigued with the low stock value relative to the value of Talbot’s credit card operation and land and buildings, along with promises for an improved product line,” said Margaret Whitfield, retail analyst at Sterne Agee.
Talbots dropped 41% on June 7 after warning that its sales would drop as profit margins were pressured by markdowns. The news raised concerns about that the retailer’s turnaround effort wasn’t working.
3.75
TLB at 3.60
Buyout candidate ?? moving easily now TLB
Will break 15 MA at 3.51 ?
TLB at 3.44
TLB looking good
Looks like it ....
TLB
TLB at 3.30
TLB at 3.30 resistance
We've appreciated your mod duties..> Thanks Wrinkles!
I've lessoned my position. Will wait to see what may come to light.